keyword
https://read.qxmd.com/read/38419687/mapping-the-intellectual-structure-of-the-research-of-omalizumab-in-chronic-spontaneous-urticaria-a%C3%A2-bibliometric-analysis
#21
JOURNAL ARTICLE
Yuxu Yao, Zhichen Liu, Jiang Ji, Qingqing Jiao
BACKGROUND: The guidelines for treating chronic spontaneous urticaria (CSU) recommend using the IgE-targeted biologic omalizumab in patients with antihistamine-refractory disease. OBJECTIVE: Our aim was to present a bibliometric review of publications related to omalizumab and CSU over the past 2 decades. METHODS: Relevant publications from 2003 to 2022 were extracted from the Science Citation Index-Expanded (SCI-EXPANDED) database in the Web of Science Core Collection database as of January 8, 2023...
May 2024: J Allergy Clin Immunol Glob
https://read.qxmd.com/read/38419351/shedding-light-on-dermographism-a-narrative-review
#22
REVIEW
Li Zhang, Cong Peng, Jie Li
Dermographism is a common subtype of chronic urticaria. It generally manifests as a linear wheal after scratching or friction, with or without angioedema. The pathophysiology is not clear, but currently, we believe that the stimulation of the skin by mechanical stress leads to the activation of mast cells, which provoke the release of histamine and pro-inflammatory mediators, ultimately forming wheal along the stressed area. The gold standard for diagnosis is a medical history and provocation test or dermatographic test...
February 28, 2024: International Journal of Dermatology
https://read.qxmd.com/read/38394074/risk-calculator-of-the-clinical-response-to-antihistamines-in-chronic-urticaria-development-and-internal-validation
#23
JOURNAL ARTICLE
Jorge Sánchez, Fabian Jaimes, Elizabeth García, Josefina Zakzuk, Ricardo Cardona, Margarita Velasquez
Early detection of CSU patients with low probability of a clinical response with antihistamines could undergo prompt initiation of therapeutic alternatives. The aim of the study was to develop and internally validate a model for predicting the clinical response to antihistamines in adult patients with chronic spontaneous urticaria (CSU), who consult allergology and dermatology care centers. A cohort of CSU patients, recruited from four participating centers, were followed up for 12 months. Fifteen candidate variables were selected to be included in the multivariate model and then internal validation was done with bootstrap analysis with 1000 simulations...
2024: PloS One
https://read.qxmd.com/read/38378094/association-between-early-patient-characteristics-and-ige-mediated-allergy-in-the-perioperative-setting
#24
JOURNAL ARTICLE
Pascale Dewachter, Claudie Mouton-Faivre, Solohaja Faniaha Dimby, Eric Vicaut, Sadek Beloucif
BACKGROUND: Early recognition of perioperative anaphylaxis, a life-threatening, usually immunoglobulin E [IgE]-mediated, immediate hypersensitivity, is essential, but bedside diagnosis is not always straightforward as clinical presentation may vary. OBJECTIVES: To describe early characteristics of perioperative immediate hypersensitivity (POH), with a special attention on cutaneous phenotypes, and identify risk factors for IgE-mediated allergy. METHODS: We retrospectively analyzed data from adults with suspected POH who were investigated in two academic medical centers...
February 18, 2024: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/38366246/-teaching-theoretical-and-practical-digital-knowledge-to-students-how-medical-students-can-learn-digital-skills-using-the-example-of-urticaria-and-angioedema
#25
JOURNAL ARTICLE
https://read.qxmd.com/read/38308655/targeting-histamine-receptor-4-in-cholinergic-urticaria-with-izuforant-leo-152020-results-from-a-phase-2a-randomised-double-blind-placebo-controlled-multicentre-crossover-trial
#26
JOURNAL ARTICLE
Eva Grekowitz, Martin Metz, Sabine Altrichter, Andrea Bauer, Knut Brockow, Guido Heine, Leonard Lionnet, Kadriye Kaplan Saday, Thomas Hultsch, Ole E Søerensen, Marcus Maurer
BACKGROUND: Cholinergic urticaria (CholU) is a common subtype of chronic inducible urticaria, where signs and symptoms (eg, pruritic wheals and angioedema) are triggered by sweating due to physical exercise, passive warming and by other sweat-inducing situations. While guidelines recommend second-generation H1 antihistamines (sgAHs), ∼90% of patients report uncontrolled disease. Targeting the histamine 4 receptor (H4R) has shown promise in preclinical/clinical studies of allergic/inflammatory diseases...
February 3, 2024: British Journal of Dermatology
https://read.qxmd.com/read/38282190/cruse-%C3%A2-an-innovative-mobile-application-for-patient-monitoring-and-management-in-chronic-spontaneous-urticaria
#27
JOURNAL ARTICLE
Sophia Neisinger, Bernardo Sousa Pinto, Aiste Ramanauskaite, Jean Bousquet, Karsten Weller, Martin Metz, Markus Magerl, Emek Kocatürk, Ivan Cherrez-Ojeda, Ana M Gimenez-Arnau, Claudio Alberto S Parisi, Sabine Altrichter, Luis Felipe Ensina, Laurence Bouillet, Riccardo Asero, Margarida Gonçalo, Carole Guillet, Krzysztof Rutkowski, Jonathan A Bernstein, Hannah Hardin, Kiran Godse, Zenon Brzoza, Jose Ignacio Larco Sousa, Simon Francis Thomsen, Martijn van Doorn, Michihiro Hide, Young-Min Ye, Staffan Vandersee, Lāsma Lapiņa, Jonny Peter, Zuotao Zhao, Lianyi Han, Iman Nasr, Heike Rockmann-Helmbach, Jennifer Astrup Sørensen, Rabia Öztaş Kara, Natalja Kurjāne, Andrii I Kurchenko, Igor Kaidashev, Vladyslav Tsaryk, Roman Stepanenko, Marcus Maurer
BACKGROUND: Chronic spontaneous urticaria (CSU) is unpredictable and can severely impair patients' quality of life. Patients with CSU need a convenient, user-friendly platform to complete patient-reported outcome measures (PROMs) on their mobile devices. CRUSE® , the Chronic Urticaria Self Evaluation app, aims to address this unmet need. METHODS: CRUSE® was developed by an international steering committee of urticaria specialists. Priorities for the app based on recent findings in CSU were defined to allow patients to track and record their symptoms and medication use over time and send photographs...
January 2024: Clinical and Translational Allergy
https://read.qxmd.com/read/38272014/one-bag-8-step-ferric-carboxymaltose-desensitization-protocol-for-patients-with-a-history-of-hypersensitivity-reactions-to-iron-preparations
#28
JOURNAL ARTICLE
Şeyma Özden, Fatma Merve Tepetam, Özge Atik
INTRODUCTION: Iron deficiency is the most common cause of anemia in both sexes, although it is more common in women. Intravenous (IV) iron replacement is preferred in patients who cannot tolerate oral treatment or when iron stores need to be replenished rapidly. In this study, we wanted to share the ferric carboxymaltose (FCM) desensitization protocol that we self-created and successfully applied. METHODS: This retrospective cross-sectional study included patients with a history of hypersensitivity reactions (HSRs) to IV or oral iron replacement and patients who were planned to receive IV iron replacement but were referred to the allergy clinic because of have risk factors (atopic diseases, history of HSR to other drugs, high serum tryptase levels, etc...
January 25, 2024: International Archives of Allergy and Immunology
https://read.qxmd.com/read/38248780/progesterone-hypersensitivity-in-assisted-reproductive-technologies-implications-for-safety-and-efficacy
#29
REVIEW
Florica Sandru, Mihai Cristian Dumitrascu, Aida Petca, Razvan-Cosmin Petca, Alexandra-Maria Roman
The global rise in the age of childbirth, influenced by changing sociodemographic patterns, has had a notable impact on fertility rates. Simultaneously, assisted reproductive techniques (ARTs) have become increasingly prevalent due to advancements in reproductive medicine. The paper explores the intersection between the surge in ARTs and the rising number of iatrogenic autoimmune progesterone dermatitis (APD). Autoimmune progesterone dermatitis, commonly known as progesterone hypersensitivity, manifests itself as a mucocutaneous hypersensitivity syndrome...
January 10, 2024: Journal of Personalized Medicine
https://read.qxmd.com/read/38219730/evaluation-of-the-effectiveness-of-the-6-warning-signs-of-the-european-society-for-immunodeficiencies-for-primary-immunodeficiencies-in-older-adults
#30
JOURNAL ARTICLE
Eray Yildiz, Fatih Çölkesen, Recep Evcen, Filiz Sadi Aykan, Mehmet Kılınç, Sevket Arslan
INTRODUCTION: Diagnostic delay in cases of primary immunodeficiency (PID) is a significant problem for clinicians, and most do not have sufficient awareness of this uncommon disorder. The European Society for Immunodeficiencies (ESID) has developed 6 warning signs to increase awareness of adult PIDs. The aim of this study was to determine the prevalence of PID in older adults regardless of the reason for presentation and to evaluate the effectiveness of the 6 warning signs of ESID in the diagnosis of PIDs...
January 12, 2024: International Archives of Allergy and Immunology
https://read.qxmd.com/read/38194789/hoign%C3%A3-s-syndrome-an-uncommon-mimicker-of-anaphylaxis-systematic-literature-review
#31
REVIEW
Danilo Consolascio, Gabriel Bronz, Pietro F Lardelli, Gregorio P Milani, Sebastiano A G Lava, Benedetta Terziroli Beretta Piccoli, Mario G Bianchetti, Marcel M Bergmann, Mattia Rizzi
The term Hoigné's syndrome denotes a mimicker of anaphylaxis, which occurs immediately after the parenteral administration of a drug and is likely caused by non-thrombotic pulmonary and systemic drug micro-embolization. It has so far been documented uniquely in case reports and small case series. Because this condition has never been systematically evaluated, we performed a structured literature review (pre-registered as CRD42023392962). The search was carried out in Excerpta Medica, National Library of Medicine, and Google Scholar...
January 8, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38192915/acquired-angioedema-and-chronic-lymphocytic-leukemia-unraveling-the-complex-interplay-and-addressing-refractory-cases
#32
Divya Shah, Radha Rishi
Acquired angioedema (AAE) due to deficiency of a C1 esterase inhibitor (C1-INH; AAE-C1-INH) is a rare and potentially fatal syndrome characterized by recurrent episodes of angioedema without urticaria. Often underdiagnosed due to its rarity and mimicry of common allergic reactions, AAE-C1-INH is associated with lymphoproliferative disorders, necessitating early recognition for improved outcomes. We present a case of a 63-year-old male diagnosed with AAE-C1-INH and concurrent stage 0 chronic lymphocytic leukemia (CLL), a rarely documented association...
December 2023: Curēus
https://read.qxmd.com/read/38191145/urticaria-and-angioedema-in-estonia-iceland-and-sweden
#33
JOURNAL ARTICLE
Johanna Heldin, Andrei Malinovschi, Shadi Amid Hägg, Thorarinn Gíslason, Bryndís Benediktsdóttir, Robert Movérare, Jenny Hallgren, Magnus Molin, Rain Jogi, Christer Janson
No abstract text is available yet for this article.
January 8, 2024: Clinical and Experimental Allergy
https://read.qxmd.com/read/38151728/a-case-control-study-for-comorbidity-and-laboratory-factors-associated-with-food-induced-anaphylaxis
#34
JOURNAL ARTICLE
Eli Magen, Eugene Merzon, Ilan Green, Avivit Golan-Cohen, Israel Magen, Shlomo Vinker, Ariel Israel
Background: Food-induced anaphylaxis (FIA) is a serious and potentially life-threatening allergic reaction triggered by food allergens. Objective: This case-control study aimed to investigate comorbidities and laboratory factors associated with FIA in the pediatric population of Israel. Methods: Retrospective data from the electronic health records of Leumit Health Care Services were used to identify 711 pediatric patients with FIA and 2560 subjects with food allergy and without anaphylaxis matched for age, gender, and ethnicity...
January 1, 2024: Allergy and Asthma Proceedings:
https://read.qxmd.com/read/38142684/online-depiction-of-urticaria-is-often-flawed-and-does-not-reflect-the-spectrum-of-clinical-manifestation
#35
JOURNAL ARTICLE
Ditte Georgina Zhang, Jennifer Astrup Sørensen, Nadja Højgaard Pedersen, Zarqa Ali, Emek Kocatürk, Marcus Maurer, Simon Francis Thomsen
BACKGROUND: The internet is a popular source of health information including images of disease manifestations. Online photographs of skin lesions may aid patients in identifying their disease, if these pictures are of good quality and of the disease they claim to show. If not, patients may be at risk of delayed diagnosis, misdiagnosis, and suboptimal treatment. For urticaria, the mismatch rate and quality of online pictures are unknown. The objective of this study was therefore to evaluate the content and quality of online images of urticaria...
December 23, 2023: Dermatology: International Journal for Clinical and Investigative Dermatology
https://read.qxmd.com/read/38141832/btk-signaling-a-crucial-link-in-the-pathophysiology-of-chronic-spontaneous-urticaria
#36
REVIEW
Jonathan A Bernstein, Marcus Maurer, Sarbjit S Saini
Chronic spontaneous urticaria (CSU) is an inflammatory skin disorder that manifests with itchy wheals, angioedema, or both for >6 weeks. Mast cells (MCs) and basophils are the key pathogenic drivers of CSU; their activation results in histamine and cytokine release with subsequent dermal inflammation. Two overlapping mechanisms of MC and basophil activation have been proposed in CSU: type I autoimmunity, also called autoallergy, mediated via IgE against various autoallergens, and type IIb autoimmunity, mediated predominantly via IgG directed against the IgE receptor FcεRI or FcεRI-bound IgE...
December 21, 2023: Journal of Allergy and Clinical Immunology
https://read.qxmd.com/read/38125294/hong-kong-macau-severe-hives-and-angioedema-referral-pathway
#37
JOURNAL ARTICLE
Philip H Li, Elaine Y L Au, Si-Leong Cheong, Ling Chung, Ka I Fan, Marco H K Ho, Agnes S Y Leung, Martin M H Chung, Jane C Y Wong, Ricardo Coelho
BACKGROUND: Urticaria (defined as the presence of hives, angioedema, or both) can be caused by a variety of etiologies ranging from more common conditions such as chronic spontaneous urticaria (CSU) to rarer conditions such as hereditary angioedema (HAE). Specialist referral may be necessary in cases of severe urticaria or HAE, but access to specialist services remains limited in certain regions, such as the Greater Bay Area (GBA) of China. To address this, the Hong Kong-Macau Severe Hives and Angioedema Referral Pathway (SHARP) was initiated by the Hong Kong Institute of Allergy and Macau Society of Dermatology to promote multidisciplinary collaboration and regional exchange of expertise in the diagnosis and management of severe urticaria...
2023: Front Allergy
https://read.qxmd.com/read/38113870/atopy-and-response-to-omalizumab-treatment-in-chronic-spontaneous-urticaria
#38
Célia Costa, Leonor Esteves Caldeira, Marisa Paulino, Diana F Santos, Susana L Silva
INTRODUCTION: The possible influence of sensitization to aeroallergens on omalizumab response in chronic spontaneous urticaria (CSU) has been insufficiently investigated. This study's aim was to investigate atopy's influence on omalizumab response in CSU patients. METHOD: Retrospective study of CSU patients followed at a Portuguese Urticaria Center of Reference and Excellence (UCARE), treated with omalizumab for at least 6 months, between 2015 and 2022. At T0, all patients underwent quantification of specific immunoglobulin E (IgE) for total extract of most prevalent aeroallergens (ImmunoCAP Thermo Fisher Scientific®) and were divided in 2 groups, according to their response to omalizumab during the first 16 weeks of treatment: responders (R) (UAS7 <7) versus partial (PR) (UAS7 = 7-15) and nonresponders (UAS7 >15)...
December 19, 2023: International Archives of Allergy and Immunology
https://read.qxmd.com/read/38078471/-not-available
#39
JOURNAL ARTICLE
Sebastian Vigand Svendsen, Natascha Gk Lange, Morten J Christensen, Charlotte G Mørtz, Carsten Bindslev-Jensen
Urticaria is a frequent skin condition presenting with wheals, angioedema or both due to the activation of mast cells. Acute urticaria (less-than 6 weeks duration) is associated with infections and allergies, whereas chronic urticaria (≥ 6 weeks) is either spontaneous (chronic spontaneous urticaria (CSU)), inducible or both. Quality of life (QoL) is frequently impaired. The pathogenesis of CSU is often of an autoimmune nature. As argued in this review, the treatment aims to restore QoL with a stepwise approach, most often using second-generation H1-antihistamines, omalizumab and cyclosporine...
December 4, 2023: Ugeskrift for Laeger
https://read.qxmd.com/read/38056692/low-prevalence-of-idiopathic-mast-cell-activation-syndrome-among-703-patients-with-suspected-mast-cell-disorders
#40
JOURNAL ARTICLE
Taleb Zaghmout, Laura Maclachlan, Nawfal Bedi, Theo Gülen
BACKGROUND: Idiopathic mast cell activation syndrome (iMCAS) is characterized by severe, episodic systemic mast cell (MC) activation and mediator-related symptoms, an event-related increase in serum tryptase levels, and response to MC-targeted therapies in the absence of underlying IgE-mediated allergy or clonal MC disorder. Studies indicating its prevalence using evidence-based diagnostic criteria are lacking. OBJECTIVE: To assess the prevalence and clinical and laboratory features of patients with iMCAS...
March 2024: Journal of Allergy and Clinical Immunology in Practice
keyword
keyword
120077
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.